FOXA1 and cancer: We find that FOXA1 mRNA is consistently the most abundant in prostate tumors compared with 25 other cancer types across patients (Fig. 1a), ranking in the 95th percentile for 492 of 497 prostate tumors profiled in TCGA (Supplementary Fig. 1a).